-
公开(公告)号:US20080058392A1
公开(公告)日:2008-03-06
申请号:US11841628
申请日:2007-08-20
IPC分类号: A61K31/192 , A61K31/433 , A61P27/06 , C07C229/06
CPC分类号: C07C405/0016
摘要: Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
摘要翻译: 描述了具有改善的药理活性和增强的耐受性的前列腺素硝基衍生物。 可用于治疗青光眼和高眼压症。
-
公开(公告)号:US07629345B2
公开(公告)日:2009-12-08
申请号:US12210975
申请日:2008-09-15
IPC分类号: A61K31/4965 , A61K31/49 , C07C69/76
CPC分类号: C07C405/0016
摘要: Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
摘要翻译: 描述了具有改善的药理活性和增强的耐受性的前列腺素硝基衍生物。 可用于治疗青光眼和高眼压症。
-
公开(公告)号:US07449469B2
公开(公告)日:2008-11-11
申请号:US11841628
申请日:2007-08-20
IPC分类号: A61K31/4965 , A61K31/49
CPC分类号: C07C405/0016
摘要: Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
摘要翻译: 描述了具有改善的药理活性和增强的耐受性的前列腺素硝基衍生物。 可用于治疗青光眼和高眼压症。
-
公开(公告)号:US07910767B2
公开(公告)日:2011-03-22
申请号:US12613985
申请日:2009-11-06
IPC分类号: C07C69/76 , A61K31/4965 , A61K31/49
CPC分类号: C07C405/0016
摘要: Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
-
公开(公告)号:US20110136904A1
公开(公告)日:2011-06-09
申请号:US13025740
申请日:2011-02-11
IPC分类号: A61K31/222 , C07C69/732 , A61P27/06
CPC分类号: C07C405/0016
摘要: Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
摘要翻译: 描述了具有改善的药理活性和增强的耐受性的前列腺素硝基衍生物。 可用于治疗青光眼和高眼压症。
-
公开(公告)号:US20100130507A1
公开(公告)日:2010-05-27
申请号:US12613985
申请日:2009-11-06
IPC分类号: A61K31/557 , C07C405/00 , C07C327/04 , C07D295/10 , C07D211/30 , A61K31/4965
CPC分类号: C07C405/0016
摘要: Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
摘要翻译: 描述了具有改善的药理活性和增强的耐受性的前列腺素硝基衍生物。 可用于治疗青光眼和高眼压症。
-
公开(公告)号:US08058467B2
公开(公告)日:2011-11-15
申请号:US13025740
申请日:2011-02-11
CPC分类号: C07C405/0016
摘要: Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
摘要翻译: 描述了具有改善的药理活性和增强的耐受性的前列腺素硝基衍生物。 可用于治疗青光眼和高眼压症。
-
公开(公告)号:US20090030076A1
公开(公告)日:2009-01-29
申请号:US12210975
申请日:2008-09-15
IPC分类号: A61K31/215 , C07C69/22 , A61P27/02
CPC分类号: C07C405/0016
摘要: Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
摘要翻译: 描述了具有改善的药理活性和增强的耐受性的前列腺素硝基衍生物。 可用于治疗青光眼和高眼压症。
-
公开(公告)号:US20070060586A1
公开(公告)日:2007-03-15
申请号:US10581450
申请日:2004-12-01
IPC分类号: A61K31/5377 , A61K31/4704 , A61K31/405 , A61K31/34 , A61K31/21
CPC分类号: C07D285/10
摘要: The present invention relates to β-adrenergic blockers nitrooxyderivatives of general formula (I): A-(Y—ONO2)s and enantiomers and diastereoisomers and pharmaceutically acceptable salts thereof, pharmaceutical compositions containing them and their use for the treatment of hypertension, cardiovascular diseases, glaucoma, migraine headache and vascular diseases.
摘要翻译: 本发明涉及通式(I)的β-肾上腺素能阻断剂硝基氧基衍生物:其对映异构体和非对映异构体及其药学上可接受的盐, 含有它们的药物组合物及其用于治疗高血压,心血管疾病,青光眼,偏头痛和血管疾病的用途。
-
公开(公告)号:US20080096908A1
公开(公告)日:2008-04-24
申请号:US11905910
申请日:2007-10-05
IPC分类号: A61K31/404 , A61K31/215 , A61K31/44 , A61P9/00 , C07D207/333 , C07D213/26 , C07D239/42 , C07D209/04 , C07C69/66 , A61K31/505 , A61K31/40
CPC分类号: C07D207/34 , C07D209/24 , C07D213/55 , C07D239/42
摘要: Statin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for treating and/or preventing several diseases, in particular coronary syndromes, neurodegenerative disorders as well as for reducing cholesterol levels.
摘要翻译: 描述了具有改善的药理活性和增强的耐受性的他汀类硝基衍生物。 它们可用于治疗和/或预防多种疾病,特别是冠状动脉综合征,神经变性疾病以及降低胆固醇水平。
-
-
-
-
-
-
-
-
-